|
Phase
|
Composition
|
max.
Temperature
[°C] *
|
Polarity
|
| OPTIMA® 1 |
dimethylpolysiloxane |
340 / 360 |
lowest
|
| OPTIMA® 1 MS |
dimethylpolysiloxane with low bleeding |
340 / 360 |
|
| OPTIMA® 1 MS Accent |
dimethylpolysiloxane with ultra-low bleeding
|
340 / 360 |
| OPTIMA® 5 |
5 % phenyl – 95 % methylpolysiloxane |
340 / 360 |
| OPTIMA® 5 MS |
5 % diphenyl – 95 % dimethylpolysiloxane with
low bleeding
|
340 / 360 |
| OPTIMA® 5 MS Accent |
silarylene phase with ultra-low bleeding: polarity
similar to 5 % diphenyl – 95 % dimethylpolysiloxane |
340 / 360 |
| OPTIMA® XLB |
silarylene phase with ultra-low bleeding:
optimised silarylene content
|
340 / 360 |
| OPTIMA® δ-3 |
autoselective polarity
between OPTIMA 5 and OPTIMA 1701 |
340 / 360 |
| OPTIMA® δ-6 |
autoselective polarity
between OPTIMA 17 and OPTIMA 210 |
340 / 360 |
OPTIMA® 35 MS
|
silarylene phase with very low bleeding: polarity
similar to 35 % diphenyl – 65 % dimethylpolysiloxane |
360 / 370
|
| OPTIMA® 17 |
phenylmethylpolysiloxane (50 % phenyl) |
300 / 320 |
| OPTIMA® 1301 |
6 % cyanopropylphenyl – 94 % dimethylpolysiloxane |
300 / 320 |
| OPTIMA® 624 |
6 % cyanopropylphenyl – 94 % dimethylpolysiloxane |
280 / 300 |
| OPTIMA® 624 LB |
6 % cyanopropylphenyl – 94 % dimethylpolysiloxane,
low bleed |
280 / 300 |
| OPTIMA® 1701 |
14 % cyanopropylphenyl – 86 % dimethylpolysiloxane |
300 / 320 |
| OPTIMA® 210 |
trifluoropropylmethylpolysiloxane (50 % trifluoropropyl) |
260 / 280 |
| OPTIMA® 225 |
50 % cyanopropylmethyl – 50 % phenylmethylpolysiloxane |
260 / 280 |
| OPTIMA® 240 |
33 % cyanopropylmethyl – 67 % dimethylpolysiloxane |
260 / 280 |
| OPTIMA® WAX |
polyethylene glycol 20000 dalton |
250 / 260 |
| OPTIMA® FFAP |
polyethylene glycol-2-nitroterephthalate |
250 / 260
|
highest |
| * first temperature for isothermal operation, second value for short isotherms in a temperature programme. Please note, that for columns with 0.53 mm ID and for columns with thicker films temperature limits are generally lower. For details refer to the description of individual phases. |